Early Stage Health Technology Assessment for Precision Biomarkers in Oral Health and Systems Medicine

av Steuten, Lotte M.G.
I publikationen OMICS (2016)

A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers

av Oosterhoff, Marije, van der Maas, Marloes E., Steuten, Lotte M. G.
I publikationen Appl Health Econ Health Policy (2015)

Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study

av de Ligt, Kelly M., Witteveen, Annemieke, Siesling, Sabine, Steuten, Lotte M. G.
I publikationen BMC Cancer (2018)

Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands

av Miquel-Cases, Anna, Steuten, Lotte M. G., Rigter, Lisanne S., van Harten, Wim H.
I publikationen BMC Cancer (2016)

Quality of integrated chronic care measured by patient survey: identification, selection and application of most appropriate instruments

av Vrijhoef, Hubertus J. M., Berbee, Rieneke, Wagner, Edward H., Steuten, Lotte M. G.
I publikationen Health Expect (2009)

Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data

av Voermans, Anne M., Mewes, Janne C., Broyles, Michael R., Steuten, Lotte M. G.
I publikationen OMICS (2019)

Effectiveness of Multidimensional Cancer Survivor Rehabilitation and Cost-Effectiveness of Cancer Rehabilitation in General: A Systematic Review

av Mewes, Janne C., Steuten, Lotte M.G., IJzerman, Maarten J., van Harten, Wim H.
Publicerad 2012

COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care

av Steuten, Lotte M.G., Creutzberg, Eva C., Vrijhoef, Hubertus J.M., Wouters, Emiel F.
I publikationen Prim Care Respir J (2006)

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients

av Miquel-Cases, Anna, Retèl, Valesca P., Lederer, Bianca, von Minckwitz, Gunter, Steuten, Lotte M. G., van Harten, Wim H.
I publikationen PLoS One (2016)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy

av Peters, Max, Piena, Marjanne A., Steuten, Lotte M.G., van der Voort van Zyp, Jochem R.N., Moerland, Marinus A., van Vulpen, Marco
I publikationen J Contemp Brachytherapy (2016)

A Call for Pharmacogenovigilance and Rapid Falsification in the Age of Big Data: Why not First Road Test Your Biomarker?

av Şardaş, Semra, Endrenyi, Laszlo, Gürsoy, Ulvi K., Hutz, Mara, Lin, Biaoyang, Patrinos, George P., Steuten, Lotte M.G., Wang, Wei, Warnich, Louise, Özdemir, Vural
I publikationen OMICS (2014)

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

av Retèl, Valesca P., Steuten, Lotte M. G., Geukes Foppen, Marnix H., Mewes, Janne C., Lindenberg, Melanie A., Haanen, John B. A. G., van Harten, Wim H.
I publikationen BMC Cancer (2018)

Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries

av Mewes, Janne C., Steuten, Lotte M. G., Groeneveld, Iris F., de Boer, Angela G. E. M., Frings-Dresen, Monique H. W., IJzerman, Maarten J., van Harten, Wim H.
I publikationen BMC Cancer (2015)

The Effectiveness of Chronic Care Management for Heart Failure: Meta-Regression Analyses to Explain the Heterogeneity in Outcomes

av Drewes, Hanneke W, Steuten, Lotte M G, Lemmens, Lidwien C, Baan, Caroline A, Boshuizen, Hendriek C, Elissen, Arianne M J, Lemmens, Karin M M, Meeuwissen, Jolanda A C, Vrijhoef, Hubertus J M
Publicerad 2012